Literature DB >> 31283068

Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.

Zhenbo Tu1, Johannes Schmöllerl1, Benjamin G Cuiffo1, Antoine E Karnoub1,2,3.   

Abstract

The fibrotic tumor microenvironment is a critical player in the pathogenesis of triple-negative breast cancers (TNBCs), with the presence of fibroblastic infiltrates particularly correlating with tumors that are clinically advanced. On this front, we previously demonstrated that TNBCs are highly enriched in fibroblastic stromal progenitor cells called mesenchymal stem/stromal cells (MSCs) and that such cells play critical roles in promoting TNBC initiation and progression. How TNBC cells respond to MSC stimulation, however, is not fully understood, and stands to reveal contextual signals used by TNBC cells during tumor development and provide biomarkers and therapeutic targets of pertinence to TNBC management. Here, we report that MSCs strongly induced the long noncoding RNA (lncRNA) LINC01133 in neighboring TNBC cells. Indeed, although lncRNAs have been tightly associated with cancer development, their contributions to breast cancer in general, and to TNBC pathogenesis in particular, have not been fully elucidated, and we set out to determine if LINC01133 regulated malignant traits in TNBC cells. We establish that LINC01133 is sufficient, on its own, in promoting phenotypic and growth characteristics of cancer stem cell-like cells, and that it is a direct mediator of the MSC-triggered miR-199a-FOXP2 pathway in TNBC models. Furthermore, we show that LINC01133 is a critical regulator of the pluripotency-determining gene Kruppel-Like Factor 4 (KLF4), and that it represents a biomarker and prognosticator of disease outcome in the clinic. Collectively, our findings introduce LINC01133 as a novel functional driver of malignancy and a potential theranostic in TNBC. Stem Cells 2019;37:1281-1292. ©AlphaMed Press 2019.

Entities:  

Keywords:  Bone marrow stromal cells; Breast cancer; Cancer stem cells; Malignancy; Mesenchymal stem cells; MicroRNA; Microenvironment; Neoplastic stem cell biology

Year:  2019        PMID: 31283068     DOI: 10.1002/stem.3055

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  16 in total

Review 1.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

Review 2.  New Sights Into Long Non-Coding RNA LINC01133 in Cancer.

Authors:  Shengnan Jiang; Qian Zhang; Jiaqi Li; Khadija Raziq; Xinyu Kang; Shiyin Liang; Chaoyue Sun; Xiao Liang; Di Zhao; Songbin Fu; Mengdi Cai
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 3.  Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer.

Authors:  Xue Hu; Qiang Zhang; Wanying Xing; Wan Wang
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 4.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

5.  Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.

Authors:  Fei-Yu Chen; Zhi-Yang Zhou; Ke-Jing Zhang; Jian Pang; Shou-Man Wang
Journal:  Cancer Cell Int       Date:  2020-10-16       Impact factor: 5.722

6.  lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer.

Authors:  Qingzhu Yang; Kai Li; Xuemei Huang; Chen Zhao; Yu Mei; Xinyuan Li; Lin Jiao; Huanjie Yang
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-11       Impact factor: 8.886

Review 7.  Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance.

Authors:  Sangita Sridharan; Cory M Howard; Augustus M C Tilley; Boopathi Subramaniyan; Amit K Tiwari; Randall J Ruch; Dayanidhi Raman
Journal:  Front Oncol       Date:  2019-10-16       Impact factor: 6.244

Review 8.  The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs.

Authors:  Justin M Brown; Marie-Claire D Wasson; Paola Marcato
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

Review 9.  The network of non-coding RNAs and their molecular targets in breast cancer.

Authors:  Francesca Crudele; Nicoletta Bianchi; Eva Reali; Marco Galasso; Chiara Agnoletto; Stefano Volinia
Journal:  Mol Cancer       Date:  2020-03-18       Impact factor: 27.401

Review 10.  Managing therapeutic resistance in breast cancer: from the lncRNAs perspective.

Authors:  Liyuan Peng; Jingwen Jiang; Bo Tang; Edouard C Nice; Yuan-Yuan Zhang; Na Xie
Journal:  Theranostics       Date:  2020-08-18       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.